Semper-B Therapeutics

Semper-B Therapeutics is a biotechnology company developing a cell-engineering platform intended to enable patients’ own cells to produce therapeutic antibodies over prolonged periods.

The approach aims to achieve durable, precise modulation of immune activity by using engineered cells as a continuing source of antibody treatment.

The company is exploring applications across multiple therapeutic areas, although specific disease indications and clinical-stage programmes have not been publicly disclosed.